spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Batard, P.
Right arrow Articles by Hatzfeld, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batard, P.
Right arrow Articles by Hatzfeld, J. A.
Ando, K. and Griffin, J. D (1995). Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Oncogene 10, 751-755.[Medline]

Becker, A. J., McCulloch, E. A, Siminovitch, L. and Till, J. E (1965). The effect of differing demands for blood cell production on DNA synthesis by hematopoietic colony-forming cells of mice. Blood 26, 296-308.[Abstract/Free Full Text]

Berardi, A. C., Wang, A., Levine, J. D., Lopez, P. and Scadden, D. T (1995). Functional isolation of human hematopoietic stem cells. Science 267, 104-108.[Abstract/Free Full Text]

Berenson, R. J., Andrews, R. G., Besinger, W. I., Kalamasz, D., Knitter, G., Buckner, C. D. and Bernstein, I. D (1988). Antigen CD34+marrow cells engraft lethally irradiated baboons. J. Clin. Invest 81, 951-955.

Berenson, R. J., Besinger, W. I., Hill, R. S,. Andrews, R. G., Garcia-Lopez, J., Kalamasz, D. F., Still, B. J., Spitzer, G, Buckner, C. D., Bernstein, I. D. and Thomas, E. D (1991). Engraftment after infusion of CD34+marrow cells in patients with breast cancer or neuroblastoma. Blood 77, 1717-1722.[Abstract/Free Full Text]

Brossard, Y., Van Nifterik, J., De Lachaux, V., Huchet, J., Chavinie, J., Francoual, C., Lemanceau, G., Benbunan, M., Gerota, I., Traineau, R.,Adam, M., Gluckman, E., Richard, P. and Thiery, D (1990). Collection of placental blood with a view to hemopoietic reconstitution. Nouv. Rev. Fr. Hematol 32, 427-429.

Caulin, C., Scholl, F. G., Frontelo, P., Gamallo, C. and Quintanilla, M (1995). Chronic exposure of cultured transformed epidermal cells to transforming growth factor1 induces an epiheliual-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ 6, 1027-1035.[Abstract]

Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F. and Shaper, J. H (1984). Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol 133, 157-165.[Abstract]

DeCoteau, J. F., Knaus, P. I., Yankelev, H., Reis, M. D., Lowsky, R., Lodish, H. F. and Kadin, M. E (1997). Loss of functional cell surface transforming growth factor(TGF- ) type I receptor correlates with insensitivity to TGF-in chronic lymphocytic leukemia. Proc. Nat. Acad. Sci. USA 94, 5877-5881.[Abstract/Free Full Text]

Dybedal, I., Guan, F., Borge, O. J., Veiby, O. P., Ramsfjell, V., Nagata, S. and Jacobsen, S. E (1997). Transforming growth factor-1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells. Blood 90, 3395-3403.[Abstract/Free Full Text]

Eaves, C. J., Cashman, J. D., Kay, R. J., Dougherty, G. J., Otsuka, T., Gaboury, L. A., Hogge, D. E., Lansdorp, P. M., Eaves, A. C. and Humphries, R. K (1991). Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78, 110-117.[Abstract/Free Full Text]

Fauser, A. A. and Messner, H. A (1978). Granulopoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood 52, 1243-1248.[Abstract/Free Full Text]

Fauser, A. A. and Messner, H. A (1979). Identification of megakaryocytes, macrophages and eosinophils in colonies of human bone marrow containing neutrophilic granulocytes and erythroblasts. Blood 53, 1023-1027.[Abstract/Free Full Text]

Fortunel, N., Batard, P., Hatzfeld, A., Monier, M.-N,. Panterne, B., Lebkowski, J. and Hatzfeld, J (1998). High Proliferative Potential-Quiescent cells: A working model to study primitive quiescent hematopoietic cells. J. Cell Sci 111, 1867-1875.[Abstract]

Garbe, A., Spyridonidis, A., Mobest, D., Schmoor, C., Mertelsmann, R. and Henschler, R (1997). Transforming growth factor-1 delays formation of granulocyte-macrophage colony-forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+haematopoietic progenitor cells. Br. J. Haematol 99, 51-958.

Grzegorzewski, K., Ruscetti, F. W., Usui, N., Damia, G., Longo, D. L., Carlino, J. A., Keller, J. R. and Wiltrout, R. H (1994). Recombinant transforming growth factor-1 and- 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J. Exp. Med 180, 1047-1057.[Abstract/Free Full Text]

Hatzfeld, J., Li, M.-L., Brown, E. L., Sookdeo, H., Levesque, J.-P., O'Toole, T., Gurney, C., Clark, S. C. and Hatzfeld, A (1991). Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor1 or Rb oligonucleotides. J. Exp. Med 174, 925-929.[Abstract/Free Full Text]

Hestdal, K., Jacobsen, S. E., Ruscetti, F. W., Longo, D. L., Boone, T. C. and Keller, J. R (1993). Increased granulopoiesis after sequential administration of transforming growth factor-1 and granulocyte-macrophage colony-stimulating factor. Exp. Hematol 21, 799-805.[Medline]

Hodgson, G. S. and Bradley, T. R (1979). Properties of hematopoietic stem cells surviving 5-fluorouracil treatment: Evidence for a pre-CFU-S cell?. Nature 281, 381-382.[Medline]

Jacobsen, S. E. W., Keller, J. R., Ruscetti, F. W., Kondaiah, P., Roberts, A. B. and Falk, L. A (1991). Bidirectionnal effects of transforming growth factor(TGF- ) on colony-stimulating factor-induced human myelopoiesis in vitro: Differential effects of distinct TGF-isoforms. Blood 78, 2239-2247.[Abstract/Free Full Text]

Jacobsen, S. E. W., Ruscetti, F. W., Ortiz, M., Gooya, J. M. and Keller, J. R (1994). The growth response of Lin-Thy-1+hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors. Exp. Hematol 22, 985-989.[Medline]

Jacobsen, S. E. W., Veiby, O. P,. Myklebust, J., Okkenhaug, C. and Lyman, S. D (1996). Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-and tumor necrosis factor-. Blood 87, 5016-5026.[Abstract/Free Full Text]

Junker, U., Knoefel, B., Nuske, K., Rebstock, K., Steiner, T., Wunderlich, H., Junker, K. and Reinhold, D (1996). Transforming Growth Factor-1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 8, 794-798.[Medline]

Kawashima, I., Zanjani, E. D., Almaida-Porada, G., Flake, A. W., Zeng, H. and Ogawa, M (1996). CD34+human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 87, 4136-4142.[Abstract/Free Full Text]

Keller, J. R., McNiece, I. K., Sill, K. T. Ellingsworth, L. R., Quesenberry, P. J., Sing, G. K. and Ruscetti, F. W (1990). Transforming Growth Factordirectly regulates primitive murine hematopoietic cell proliferation. Blood 75, 596-602.[Abstract/Free Full Text]

Keller, J. R., Jacobsen, S. E., Dubois, C. M., Hestal, K. and Ruscetti, F. W (1992). Transforming growth factor-: A bidirectionnal regulator of hematopoietic cell growth. Int. J. Cell Cloning 10, 2-11.[Abstract]

Keller, J. R., Mantel, C., Sing, G. K., Ellingsworth, L. R., Ruscetti, S. K. and Ruscetti, F. W (1998). Transforming Growth Factor-1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med 168, 737-750.[Abstract/Free Full Text]

Kishi, K., Ellingsworth, L. R. and Ogawa, M (1989). The suppressive effects of typetransforming growth factor (TGF- ) on primitive murine hemopoietic progenitors are abrogated by interleukin-6 and granulocyte colony-stimulating factor. Leukemia 3, 687-691.[Medline]

Krause, D. S., Fackler, M. J., Civin, C. I. and May, W. S (1996). CD34: Structure, biology, and clinical utility. Blood 87, 1-13.[Free Full Text]

Le Bousse-Kerdiles, M. C., Chevillard, S., Charpentier, A., Romquin, N., Clay, D., Smadja-Joffe, F., Praloran, V., Dupriez, B., Demory, J. L., Jasmin, C. and Martyre, M. C (1996). Differential expression of transforming growth factor-, basic fibroblast growth factor, and their receptors in CD34+hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88, 4534-4546.[Abstract/Free Full Text]

Lemoli, R. M., Strife, A., Clarkson, B. D., Haley, J. D. and Gulati, S. D (1992). TGF-3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro. Exp. Hematol 20, 1252-1256.[Medline]

Li, M.-L., Cardoso, A. A., Sansilvestri, P., Hatzfeld, A., Brown, E. L., Sookdeo, H., Levesque, J.-P., Clark, S. C. and Hatzfeld, J (1994). Additive effects of steel factor and antisense TGF-1 oligodeoxynucleotide on CD34+hematopoietic progenitor cells. Leukemia 8, 441-445.[Medline]

Lotem, J. and Sachs, L (1992). Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80, 1750-1757.[Abstract/Free Full Text]

Massague, J (1990). The transforming growth factorfamily. Annu. Rev. Cell Biol 6, 597-641.

Miettinen, P. J., Ebner, R., Lopez A. R. and Derynck R (1994). TGF-induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J. Cell. Biol 127, 2021-2036.[Abstract/Free Full Text]

Ohta, M., Greenberger, J. S., Anklesaria, P., Bassols, A. and Massague, J (1987). Two forms of transforming growth factor-distinguished by multipotential haematopoietic progenitor cells. Nature 329, 539-541.[Medline]

Ottmann, O. G. and Pelus, L. M (1988). Differential proliferative effects of transforming growth factor-on human hematopoietic progenitor cells. J. Immunol 140, 2661-2665.[Abstract]

Petersen, B. E., Bowen, W. C. Patrene, K. D., Mars, W. M., Sullivan, A. K., Murase, N., Boggs, S. S., Greenberger, J. S. and Goff, J. P (1999). Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170.[Abstract/Free Full Text]

Ploemacher, R. E., Van Soest, P. L. and Boudewijn, A (1993). Autocrine transforming growth factor1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor. Stem Cells 11, 336-347.[Abstract]

Puolakkainen, P. A., Ranchalis, J. E., Gombotz, W. R., Hoffman, R. J. and Twardzik, D. R (1994). Novel delivery system for inducing quiescence in intestinal stem cells in rats by transforming growth factor beta1. Gastroenterology 107, 1319-1326.[Medline]

Rifkin, D. B., Mazzieri, R., Munger, J. S., Noguera, I. and Sung, J (1999). Proteolytic control of growth factor availability. APMIS 107, 80-85.[Medline]

Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F. and Sporn, M. B (1985). Typetransforming growth factor: A bifunctionnal regulator of cellular growth. Proc. Nat. Acad. Sci. USA 82, 119-123.[Abstract/Free Full Text]

Robinson, S. D., Silberstein, G. B., Roberts, A. B., Flanders, K. C. and Daniel, C. W (1991). Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development 113, 867-878.[Abstract]

Sansilvestri, P., Cardoso, A. A., Batard, P., Panterne, B., Hatzfeld, A., Lim, B., Levesque, J.-P., Monier, M.-N. and Hatzfeld, J (1995). Early CD34highcells can be separated into KIThighcells in which transforming growth factor-(TGF- ) downmodulates c-kit and KITlowcells in which anti-TGF-upmodulates c-kit. Blood 86, 1729-1735.[Abstract/Free Full Text]

Sargiacomo, M., Valtieri, M., Gabbianelli, M., Pelosi, E., Testa, U. Camagna, A. and Peschle, C (1991). Pure human hematopoietic progenitors: Direct inhibitory effect of transforming growth factors-1 and- 2. Ann. NY Acad. Sci 628, 84-91.[Abstract]

Sing, G. K., Keller, J. R., Ellingsworth, L. R. and Ruscetti, F. W (1988). Transforming growth factorselectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72, 1504-1511.[Abstract/Free Full Text]

Sitnicka, E., Ruscetti, F. W., Priestley, G. V., Wolf, N. S. and Bartelmez, S. H (1996). Transforming growth factor1 directly and reversibly inhibits the initial cell division of long-term repopulating stem cells. Blood 88, 82-88.[Abstract/Free Full Text]

Suda, T., Suda, J. and Ogawa, M (1983). Proliferative kinetics and differentiation of murine blast cell colonies in culture: Evidence for variable G0periods and constant doubling rates of early pluripotent hemopoietic progenitors. J. Cell. Physiol 117, 308-318.[Medline]

Taetle, R., Payne, C., Dos Santos, Russell, B. and Segarini, P (1993). Effects of transforming growth factor1 on growth and apoptosis of human acute myelogenous leukemia cells. Cancer Res 53, 3386-3393.[Abstract/Free Full Text]

Till, J. E. and McCulloch, E. A (1961). Direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res 14, 213-222.[Medline]

Till, J. E., McCulloch, E. A. and Siminovitch, L (1964). A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc. Nat. Acad. Sci. USA 51, 29-36.[Free Full Text]

Turley, J. M., Falk, L. A., Ruscetti, F. W., Kasper, J. J., Francomano, T., Fu, T., Bang, O. S. and Birchenall-Roberts, M.-C (1996). Transforming growth factor1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Cell Growth Differ 7, 1535-1544.[Abstract]

Veiby, O. P., Jacobsen, F. W., Cui, L., Lyman, S. D. and Jacobsen, S. E. W (1996). The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-and TGF-. J. Immunol 157, 2953-2960.[Abstract]

Verfaillie, C. M (1998). Adhesion receptors as regulators of the hematopoietic process. Blood 92, 2609-2612.[Free Full Text]

Zhou, Y. Q., Stanley, E. R., Clark, S. C., Hatzfeld, J., Levesque, J.-P., Federici, C., Watt, S. M. and Hatzfeld, A (1998). Interleukin-3 and interleukin-1a allow earlier bone marrow progenitors to respond to human colony-stimulating factor 1. Blood 72, 1870-1874.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Brunsing, S. A. Omori, F. Weber, A. Bicknell, L. Friend, R. Rickert, and M. Niwa
B- and T-cell Development Both Involve Activity of the Unfolded Protein Response Pathway
J. Biol. Chem., June 27, 2008; 283(26): 17954 - 17961.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood, January 15, 2008; 111(2): 492 - 503.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. L. Goldberg, O. Alpdogan, S. J. Muriglan, M. V. Hammett, M. K. Milton, J. M. Eng, V. M. Hubbard, A. Kochman, L. M. Willis, A. S. Greenberg, et al.
Enhanced Immune Reconstitution by Sex Steroid Ablation following Allogeneic Hemopoietic Stem Cell Transplantation
J. Immunol., June 1, 2007; 178(11): 7473 - 7484.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Blank, G. Karlsson, J. L. Moody, T. Utsugisawa, M. Magnusson, S. Singbrant, J. Larsson, and S. Karlsson
Smad7 promotes self-renewal of hematopoietic stem cells
Blood, December 15, 2006; 108(13): 4246 - 4254.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. Campard, M. Vasse, S. Rose-John, F. Poyer, M. Lamacz, and J.-P. Vannier
Multilevel Regulation of IL-6R by IL-6-sIL-6R Fusion Protein According to the Primitiveness of Peripheral Blood-Derived CD133+ Cells
Stem Cells, May 1, 2006; 24(5): 1302 - 1314.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Z. Hmama, K. Sendide, A. Talal, R. Garcia, K. Dobos, and N. E. Reiner
Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1{alpha},25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway
J. Cell Sci., April 15, 2004; 117(10): 2131 - 2140.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. M. Bohmer
IL-3-Dependent Early Erythropoiesis Is Stimulated by Autocrine Transforming Growth Factor Beta
Stem Cells, March 1, 2004; 22(2): 216 - 224.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Larsson, U. Blank, H. Helgadottir, J. M. Bjornsson, M. Ehinger, M.-J. Goumans, X. Fan, P. Leveen, and S. Karlsson
TGF-{beta} signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro
Blood, November 1, 2003; 102(9): 3129 - 3135.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. O. Fortunel, J. A. Hatzfeld, P.-A. Rosemary, C. Ferraris, M.-N. Monier, V. Haydont, J. Longuet, B. Brethon, B. Lim, I. Castiel, et al.
Long-term expansion of human functional epidermal precursor cells: promotion of extensive amplification by low TGF-{beta}1 concentrations
J. Cell Sci., October 1, 2003; 116(19): 4043 - 4052.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Akel, C. Petrow-Sadowski, M. J. Laughlin, and F. W. Ruscetti
Neutralization of Autocrine Transforming Growth Factor-{beta} in Human Cord Blood CD34+CD38-Lin- Cells Promotes Stem-Cell-Factor-Mediated Erythropoietin-Independent Early Erythroid Progenitor Development and Reduces Terminal Differentiation
Stem Cells, September 1, 2003; 21(5): 557 - 567.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Chen, G. Zhou, T. Juan, S. M. Colicos, J. P. Cannon, M. Cabriera-Hansen, C. F. Meyer, R. Jurecic, N. G. Copeland, D. J. Gilbert, et al.
The Dual Specificity JKAP Specifically Activates the c-Jun N-terminal Kinase Pathway
J. Biol. Chem., September 20, 2002; 277(39): 36592 - 36601.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Dao, J. Hwa, and J. A. Nolta
Molecular mechanism of transforming growth factor beta -mediated cell-cycle modulation in primary human CD34+ progenitors
Blood, January 15, 2002; 99(2): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld
Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis
Blood, September 15, 2000; 96(6): 2022 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Spagnoli, C Cicchini, M Tripodi, and M. Weiss
Inhibition of MMH (Met murine hepatocyte) cell differentiation by TGF(beta) is abrogated by pre-treatment with the heritable differentiation effector FGF1
J. Cell Sci., January 10, 2000; 113(20): 3639 - 3647.
[Abstract] [PDF]


This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Batard, P.
Right arrow Articles by Hatzfeld, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batard, P.
Right arrow Articles by Hatzfeld, J. A.